心肺體外循環設備的全球市場 - 市場規模(各市場區隔)，佔有率，法規，償付，運作台數，預測(～2036年)

本報告提供全球心肺體外循環設備市場相關調查分析，提供各地區市場規模，主要趨勢，創新的產品與技術，競爭情形等資訊。

市場模型的主要組成如下：

已上市的體外循環設備和不斷變化的競爭格局

• 主要產業趨勢分析
• 心肺旁路設備市場各細分市場的年收入及市場預測（2015-2036 年）
• 有關幹預總數、單位數量、平均銷售價格和每個細分市場的市場價值的詳細數據

全球、區域和國家層面的市場洞察

• 按地區和全球趨勢細分的定性市場訊息，並提供每個國家/地區的市場洞察
• 心肺旁路設備市場的 SWOT 分析
• 心肺旁路設備市場的競爭動態考量與趨勢

透過獲得真正的整體視角（包括醫療保健系統概述）來了解您的市場。此外，市場進入部分提供有關報銷政策和監管環境的信息，從而可以更深入地了解市場動態。

• 各國醫療保健體系概述
• 各國的報銷政策
• 各國醫療科技監理狀況

對象企業

• LivaNova Plc
• Medtronic Plc
• Terumo Corp
• Getinge AB
• Braile Biomedica Ltda
• Senko Medical Instrument Manufacturing Co Ltd
• Technowood Corp
• Abiomed Inc
• 其他

Cardiopulmonary Bypass Equipment Market Size by Segments, Share, Regulatory, Reimbursement, Installed Base and Forecast to 2036 is built to visualize quantitative and qualitative market trends within Cardiovascular Devices therapeutic area.

Cardiopulmonary bypass equipment temporarily takes over the function of heart and lungs during an open-heart surgery. Hence, also known as heart-lung machine. The equipment is used to divert the blood returning to the heart, before it returns to the arterial circulation. It works both as a heart i.e., pumps blood and as lungs i.e., supply oxygenated blood to the RBCs.

CPB is routinely used for various cardiac and non-cardiac surgical operations. Cardiopulmonary bypass machines are used during open-heart surgery. The machine helps to bypass the heart so that surgeons can work after the heart is emptied during the surgery. Once the surgery is done and heart starts pumping normally, the heart lung machine is disconnected. The heart-lung machine can take over the work of the heart and lungs for several hours.

Each of the covered 39 country's color-coded and fully-sourced market models are equipped with installed base. The interactive excel deliverable covers installed base, new sales volumes, product usage, average selling prices, market size and company share/rank analysis (wherever available). Moreover, analyst comments with qualitative insight offer context for quantitative data.

Key Inclusions of the market model are -

Currently marketed Cardiopulmonary Bypass Equipment and evolving competitive landscape -

• Insightful review of the key industry trends.
• Annualized total Cardiopulmonary Bypass Equipment market revenue by segment and market outlooks from 2015-2036.
• Granular data on total interventions, units, average selling prices and market values by segment.

Global, Regional and Country level market specific insights -

• Qualitative market specific information is available with global trends further broken down into regional trends. In addition GlobalData analysts provide unique country specific insights on the market.
• SWOT analysis for Cardiopulmonary Bypass Equipment market.
• Competitive dynamics insights and trends provided for Cardiopulmonary Bypass Equipment market.

Drive the understanding of the market by getting the veritable big picture including an overview of the healthcare system. In addition the Market Access segment allows you to delve deeper into market dynamics with information on reimbursement policies and the regulatory landscape.

• Country specific overview of the healthcare system.
• Country specific reimbursement policies.
• Country specific medtech regulatory landscape.

Robust methodologies and sources enable the model to provide extensive and accurate overview of the market. Demand and supply-side primary sources are integrated within the syndicated models, including Key Opinion Leaders. In addition, real world data sources are leveraged to determine market trends; these include government procedure databases, hospital purchasing databases, and proprietary online databases.

Companies covered: LivaNova Plc, Medtronic Plc, Terumo Corp, Getinge AB, Braile Biomedica Ltda, Senko Medical Instrument Manufacturing Co Ltd, Technowood Corp, Abiomed Inc, and Others.

Countries covered: United States, United Kingdom, Germany, France, Italy, Spain, Brazil, China, India, Russia, Japan, Australia, Canada, Mexico, South Korea, Denmark, Ireland, Netherlands, New Zealand, South Africa, Sweden, Switzerland, Austria, Belgium, Finland, Israel, Norway, Poland, Portugal, Taiwan, Czech Republic, Greece, Hungary, Turkey, Egypt, Saudi Arabia, United Arab Emirates, Argentina and Chile.

Scope

This Market Model gives important, expert insight you won't find in any other source. The model illustrates qualitative and quantitative trends within the specified market. This model is required reading for -

• CMO executives who must have deep understanding of the Cardiopulmonary Bypass Equipment marketplace to make strategic planning and investment decisions.
• Sourcing and procurement executives who must understand crucial components of the supply base in order to make decisions about supplier selection and management.
• Private equity investors that need a deeper understanding of the market to identify and value potential investment targets.

Reasons to Buy

The model will enable you to -

• Develop and design your in-licensing and out-licensing strategies through a review of pipeline products, by identifying key companies.
• Develop business strategies by understanding the trends shaping and driving Cardiopulmonary Bypass Equipment market.
• Drive revenues by understanding the key trends, innovative products and technologies, market segments, and companies likely to impact the Cardiopulmonary Bypass Equipment market in the future.
• Formulate effective sales and marketing strategies by understanding the competitive landscape and by analyzing the company share of market leaders.
• Identify emerging players with potentially strong product portfolios and create effective counter-strategies to gain a competitive advantage.
• Track device sales in the global and country-specific Cardiopulmonary Bypass Equipment market from 2015-2036.
• Organize your sales and marketing efforts by identifying the market categories and segments that present maximum opportunities for consolidations, investments and strategic partnerships.